Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP3 | P08254 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 2/20 | 0.51 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.51 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL781062 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL782619 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL9631708 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL782330 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL782146 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL782182 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL25227699 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL3166863 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL782296 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 | |
| SCHEMBL781101 | 1.00 | CES2 (0.52) | CES2CES1MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071530-A1 | AGROCHEMICAL COMPOSITION AND METHOD FOR PREPARING AND USING THE SAME | ROTAM AGROCHEM INTERNATIONAL CO., LTD. (CN) | 2012-03-22 | — | — | US | claimed |
| US-8653121-B2 | Agrochemical composition and method for preparing and using the same | ROTAM AGROCHEM INTERNATIONAL CO., LTD. (CN) | 2014-02-18 | — | — | US | disclosed |
| US-20120071530-A1 | AGROCHEMICAL COMPOSITION AND METHOD FOR PREPARING AND USING THE SAME | ROTAM AGROCHEM INTERNATIONAL CO., LTD. (CN) | 2012-03-22 | — | — | US | disclosed |
| US-5118845-A | N-butyl, N-dodecylacetamide | WHITBY RESEARCH, INC. (US) | 1992-06-02 | — | — | US | disclosed |
| EP-0268220-B1 | PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS | WHITBY RESEARCH, Inc. (US) | 1992-05-20 | — | — | EP | disclosed |
| US-4902676-A | PENETRATION ENHANCING AND PHYSIOLOGICALLY ACTIVE AGENTS; THROUGH THE SKIN OR MUCOSAL MEMBRANE | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1990-02-20 | — | — | US | disclosed |
| EP-0329669-A4 | COMPOSITIONS COMPRISING N,N-DIALKYLALKANAMIDES AND THEIR USES. | NELSON RES & DEV COMPANY (US) | 1989-12-12 | — | — | EP | disclosed |
| EP-0329669-A1 | COMPOSITIONS COMPRISING N,N-DIALKYLALKANAMIDES AND THEIR USES | Whitby Research Incorporated (US) | 1989-08-30 | — | — | EP | disclosed |
| US-4808414-A | DRUG DELIVERY BY SKIN ABSORPTION | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1989-02-28 | — | — | US | disclosed |
| EP-0268220-A2 | Penetration enhancers for transdermal delivery of systemic agents | WHITBY RESEARCH, Inc. (US) | 1988-05-25 | — | — | EP | disclosed |
| WO-1988002216-A1 | COMPOSITIONS COMPRISING N,N-DIALKYLALKANAMIDES AND THEIR USES | NELSON RESEARCH AND DEVELOPMENT COMPANY (US) | 1988-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071530-A1 | AGROCHEMICAL COMPOSITION AND METHOD FOR PREPARING AND USING THE SAME | CYP2F1, CYP51A1, CYP4F3 | CES2 239/4885CES1 240/4885MMP1 4399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.